Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision MedicineTetsuya Fujimura, Satoshi Inoue|Cancers|2018Cited by 31
Clinical outcomes in donors and recipients of kidney transplantations involving medically complex living donors – a retrospective studyYoshitaka Kinoshita, Tetsuya Fujimura, Takashi Yagisawa et al.|Transplant International|2020Cited by 11
Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysisSatoru Taguchi, Haruki Kume, Yume Adachi et al.|International Journal of Urology|2024Cited by 4
Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomyYuta Yamada, Haruki Kume, Yoichi Fujii et al.|Scientific Reports|2024Cited by 4
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysisSatoru Taguchi, Haruki Kume, Taketo Kawai et al.|Research Square|2024Cited by 2